pharmaadvancement.com   Monthly E-Newsletter - November 2022
PMIBD
Pharma Advancement Newsletter
Pharma Advancment news letter subscribe Advertise With Us
November - 2022 - Volume 11 I Pharma Advancement E-Newsletter
  Pharma Advancement on LinkedIn Pharma Advancement on Facebook
Market Insights  
$2 Million Gene Therapy Might Become The Standard In The US
Lately, slow development of personalised medications has largely been attributed, in part, to outrageously expensive gene treatments that have been developed.
Pharma In Africa Needs Indigenous Emphasis And Investment
Report Indicates UK £62bn Behind In Global R&D Investment
OSD Contract Manufacturing To Hit $54.7 Billion by 2030
Pharma Exports of India Grew 138% From 2013-14
India Seeks Better Pharma Market Access In The UK
Due to planned regulatory cooperation with Medicines and Healthcare Products in UK Regulatory Agency, India-UK accord is likely to benefit pharma business.
Advertise Your Content  
Advertise in Our Next Issue - Contact
E: peter@pharmaadvancement.com
W: www.pharmaadvancement.com
Research Updates  
Australia Approves Faecal Transplants For Intestinal Health
Currently, transplants are administered via the colon, however, it is anticipated that oral administration will become available in the not-too-distant future.
Oxford Researchers Uncover The Root Behind Type 2 Diabetes
According to findings of the study, chronic hyperglycaemia is the cause of beta-cell failure, which is an obvious factor in the development of type 2 diabetes.
Leprosy-Causing Bacteria May Be Able To Regenerate Livers
The bacteria that cause leprosy took advantage of the natural ability of the liver to heal itself to make the organ bigger and give new cells more room to grow.
Research Offers Neurodegenerative Disease Patients Optimism
The ground-breaking breakthrough may present a glimmer of hope in the campaign against conditions that currently have no cures, such as Alzheimers disease.
Study Bringing Personalised Immunotherapy Therapies Closer
According to the findings of the research, formulating prescriptions based entirely on the levels of proteins already existing is unlikely to be appropriate.
Popular Events
Advanced Wound Care Summit Europe 2022
2022-12-13 - 2022-12-14
TBC, Berlin, Germany
W: www.advancedwoundcareeu.com
Precision Medicine in Inflammatory Bowel Disease Summit 2023
2023-01-30 - 2023-02-01
Embassy Suites Boston Logan Airport , Boston, USA
W: https://ter.li/9g3fb4
PMIBD

pharmaadvancement.com

     

Editorial Inquiries

Advertising Inquiries